Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain
NCT00142519 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2019-03-15
Summary
This is a randomized Phase II study testing the effectiveness of the combination of morphine and methadone versus morphine alone in relieving pain. A second goal is to further evaluate any side effects of the combination of morphine and methadone.
Conditions
Interventions
- DRUG
-
Methadone
Upon the 1st request for analgesic medication morphine 2 mg, upon the 2nd request for analgesic medication morphine 2 mg
- DRUG
-
methadone and morphine
Upon the 1st request for analgesic medication morphine 2 mg, upon the 2nd request for analgesic medication morphine 1 mg and methadone 1 mg
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Natalia Moryl, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- United States
Study Locations
More Related Trials
-
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
NCT00634010 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine
NCT02145975 ·Status: COMPLETED ·Phase: PHASE3
-
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
NCT00726830 ·Status: TERMINATED ·Phase: NA
-
Methadone for 'Adenocarcinopathic' Pain Treatment
NCT05325164 ·Status: WITHDRAWN ·Phase: PHASE3
-
Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study
NCT00184496 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose IV Methadone for Post-Op Pain
NCT05425420 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.
NCT05587998 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
NCT00216658 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Effects of Methadone for Cancer Pain
NCT02856399 ·Status: UNKNOWN
-
Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects
NCT01924182 ·Status: TERMINATED ·Phase: NA
-
Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer
NCT03936205 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients
NCT04779567 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?
NCT01317589 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
NCT02289261 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants
NCT04448561 ·Status: COMPLETED ·Phase: PHASE1
-
Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer
NCT00712712 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Interactions of Cannabidiol (CBD) With Morphine
NCT05143424 ·Status: RECRUITING ·Phase: PHASE1
-
Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain
NCT04533243 ·Status: UNKNOWN ·Phase: PHASE3
-
Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
NCT01816503 ·Status: COMPLETED
-
Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment
NCT01326325 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Characterization of the Active, Separated System With PK Controller (Fentanyl Iontophoretic Transdermal System, 40 Mcg Fentanyl Per Activation).
NCT01750060 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
NCT00101621 ·Status: TERMINATED ·Phase: PHASE2
-
Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine
NCT00256347 ·Status: COMPLETED ·Phase: NA
-
A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects
NCT00635063 ·Status: TERMINATED ·Phase: PHASE3
-
Morphine for the Treatment of Pain in Patients With Breast Cancer
NCT00003000 ·Status: COMPLETED